| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenues, net | $11.4M+31.5% | $8.7M+112.5% | $4.1M+99.7% | $2.0M |
| Cost of revenues | $6.9M+16.4% | $5.9M+59.9% | $3.7M+107.3% | $1.8M |
| Gross profit | $4.5M+64.1% | $2.7M+634.8% | $374K+46.1% | $256K |
| Research and development | $2K-97.4% | $78K-24.3% | $103K-71.9% | $367K |
| Selling, general and administrative | $7.9M+26.3% | $6.2M+66.1% | $3.7M+15.8% | $3.2M |
| Total operating expenses | $7.9M+24.7% | $6.3M+63.6% | $3.9M+6.9% | $3.6M |
| Loss from operations | -$3.4M+5.7% | -$3.6M-2.2% | -$3.5M-3.9% | -$3.3M |
| Change in fair value of warrant liability, net of warrant modification expense | $118K+321.4% | $28K-70.8% | $96K+26.3% | $76K |
| Realized gain on investments in marketable securities | $68K | — | $191K+2022.2% | $9K |
| Interest expense, net | -$34K+58.0% | -$81K-440.0% | -$15K+98.9% | -$1.3M |
| Change in fair value of contingent consideration | -$18K | — | — | — |
| Gain in spin-off of NexGelRx | $162K | — | — | — |
| Other expense | -$73K-1725.0% | -$4K-100.0% | -$2K | — |
| Other income | $286K+191.8% | $98K+415.8% | $19K+533.3% | $3K |
| Total other income (expense), net | $459K+404.4% | $91K-68.5% | $289K+120.7% | -$1.4M |
| Loss before income taxes | -$2.9M+16.5% | -$3.5M-8.6% | -$3.2M+32.8% | -$4.7M |
| Net loss | -$2.9M+16.5% | -$3.5M-8.6% | -$3.2M+32.8% | -$4.7M |
| Less: Loss attributable to non-controlling interest in joint venture | -$107K-158.8% | $182K+487.1% | $31K | — |
| Net loss attributable to NexGel stockholders | -$3.0M+8.6% | -$3.3M-3.9% | -$3.2M+33.5% | -$4.7M |
| Net loss per common share - basic | -$380.00+24.0% | -$500.00+10.7% | -$560.00+34.1% | -$850.00 |
| Net loss per common share - diluted | -$380.00+24.0% | -$500.00+10.7% | -$560.00+34.1% | -$850.00 |
| Weighted average shares used in computing net loss per common share - basic | $7854288000.00+20.6% | $6511574000.00+14.8% | $5671842000.00+1.7% | $5574818000.00 |
| Weighted average shares used in computing net loss per common share - diluted | $7854288000.00+20.6% | $6511574000.00+14.8% | $5671842000.00+1.7% | $5574818000.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.